Abstract
Cancer-related cognitive impairment (CRCI), also known as chemobrain or cancerbrain, represents cognitive impairment among cancer patients and survivors. There has been a growing interest in better understanding the perspectives and experiences of patients with CRCI, as well as its impact on their daily lives. A survey program was conducted by Kantar Health, an independent research agency, in collaboration with RoseUp, a French national cancer patient Non-Governmental Organization, to assess the health-related quality of life (QoL) of female breast cancer patients with self-reported CRCI in France.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
